Patents by Inventor Allison Ruth Northcutt

Allison Ruth Northcutt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for treating irritable bowel syndrome
    Patent number: 6593336
    Abstract: This invention relates to the use of 5-HT3 receptor antagonists in the treatment of nonconstipated female IBS patients.
    Type: Grant
    Filed: June 10, 2002
    Date of Patent: July 15, 2003
    Assignee: SmithKline Beecham Corporation
    Inventors: Allen Wayne Mangel, Allison Ruth Northcutt
  • Methods for treating irritable bowel syndrome
    Publication number: 20030036549
    Abstract: This invention relates to the use of 5-HT3 receptor antagonists in the treatment of nonconstipated female IBS patients.
    Type: Application
    Filed: June 10, 2002
    Publication date: February 20, 2003
    Inventors: Allen Wayne Mangel, Allison Ruth Northcutt
  • Methods for treating irritable bowel syndrome
    Patent number: 6429209
    Abstract: This invention relates to the use of 5-HT3 receptor antagonists in the treatment of nonconstipated female IBS patients.
    Type: Grant
    Filed: April 13, 2001
    Date of Patent: August 6, 2002
    Assignee: SmithKline Beecham Corporation
    Inventors: Allen Wayne Mangel, Allison Ruth Northcutt
  • Medicaments
    Publication number: 20010044450
    Abstract: This invention relates to the use of 5-HT3 receptor antagonists in the treatment of nonconstipated female IBS patients.
    Type: Application
    Filed: April 13, 2001
    Publication date: November 22, 2001
    Inventors: Allen Wayne Mangel, Allison Ruth Northcutt
  • Medicaments for the treatment of non-constipated female irritable bowel syndrome
    Patent number: 6284770
    Abstract: This invention relates to the use of 5-HT3 receptor antagonists in the treatment of nonconstipated female IBS patients.
    Type: Grant
    Filed: April 5, 2000
    Date of Patent: September 4, 2001
    Assignee: Glaxo Wellcome Inc.
    Inventors: Allen Wayne Mangel, Allison Ruth Northcutt